Who Paid My Doc
Proof of concept and DRF in BPD
Research payments
$3,708,335
Through program year 2025, $3,708,335 in research payments was reported against Proof of concept and DRF in BPD, across 240 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $250 | 1 |
| 2024 | Research | $409,138 | 11 |
| 2023 | Research | $605,573 | 45 |
| 2022 | Research | $1,599,972 | 55 |
| 2021 | Research | $1,035,870 | 93 |
| 2020 | Research | $57,532 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Benny Barnhart Wichita Falls, TX Named on 13 payments
- Sarah Land Tulsa, OK Named on 9 payments
- Sarah Fineberg New Haven, CT Named on 9 payments
- Sana Johnson-Quijada Temecula, CA Named on 9 payments
- Steven MacIna Anaheim, CA Named on 7 payments
- Steven Dubovsky Buffalo, NY Named on 6 payments
- Zaheer Aslam Fort Myers, FL Named on 6 payments
- Angelo Sambunaris Alpharetta, GA Named on 6 payments
- Elias Sarkis Gainesville, FL Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.